Skip to main content

Leland Gershaw

Analyst

Oppenheim & Co.

Equibles does not estimate personal net worth.

About Leland Gershaw

Leland Gershaw is recorded as Analyst at Oppenheim & Co.. Leland Gershaw has spoken on 1 earnings call across 1 company, most recently for UroGen Pharma Ltd. on November 4, 2026. The companies whose calls Leland Gershaw spoke on are classified in the Healthcare sector.

Leland Gershaw on recent calls

“First, we just want to drill in a bit, Mark, on your comments about, you know, sort of the type of patient who would be the go-to for Zesteri versus another terp.”
Analyst — Oppenheim & Co., UroGen Pharma Ltd. Q3 FY2026 Earnings Call ·

Affiliation history

  • Oppenheim & Co.

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity